← Back to directory
WP
Wellington Partners Venture Capital
Munich, GermanyWebsite ↗
Wellington Partners Venture Capital is a leading European venture capital firm founded in 1998, specializing in early- and growth-stage investments in life sciences and technology companies across Europe. The firm aims to support outstanding entrepreneurs in transforming their innovative ideas into market-leading businesses.
Last raised
Jan 2017
9y 7mo ago
Latest fund size
$226M
Wellington Partners Life Science Fund V
AUM
$860M
estimated
Funds raised
Capital this firm has raised, newest first
Wellington Partners Life Science Fund V
Jan 2017 · WPLS-V
$226M
Wellington Partners III Technology Fund
Jan 2013
$162M
WPLS IV
Jan 2012
$5.4M
Wellington Partners IV Technology
Jan 2008
$285M
Wellington Partners Ventures III Life Science Fund
Feb 2007 · WPLS III
$53.8M
Wellington II
Jun 2000 · WP II
$225.8M
Wellington I
Jan 1998 · WP I
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Beren Therapeutics | Growth | — | Jun 2026 | |
| Nuclidium | Series B | $117M | May 2026 | |
| Polares Medical | Growth | $50M | Mar 2026 | |
| AMBOSS | Growth | — | Mar 2025 | |
| SciRhom GmbHLead | Series A | $70M | Jul 2024 | |
| Aignostics | Series A | $15M | Sep 2022 | |
| Dunad Therapeutics | Series A | $50M | Oct 2021 | |
| Seamless Therapeutics | Seed | $13.5M | Sep 2021 |
Sources
Where this data came from